Beijing Designates 923 Medical Entities for National Reimbursement Drug List
The Beijing Municipal Medical Insurance Bureau has released a notification indicating that a total of...
Policy / Regulatory
NHSA Launches Expert Review for 2025 NRDL Update in China
The National Healthcare Security Administration (NHSA) announced on September 16 the commencement of the expert...
Hainan’s Lecheng Zone Updates Special Drug Insurance List with Expanded Coverage
Hainan Boao Lecheng International Medical Tourism Pilot Zone has released an updated special drug insurance...
US Blocks Asymchem’s Acquisition of Snapdragon Chemistry
US authorities have intervened to block the purchase of US-based Contract Development and Manufacturing Organization...
CDE Issues Guidelines for Anti-Tumor ADC Clinical Development
The Center for Drug Evaluation (CDE) has released the “Technical Guidelines for Clinical Research and...
China’s Policy Shifts Medical Device Procurement Toward Domestic Products
Local government policies in China have begun to direct public hospitals to prioritize the procurement...
NMPA Releases 58th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 58th batch of reference drugs for...
Guangdong Launches Free HPV Vaccination Program for School-aged Girls
Guangdong province has rolled out a free HPV vaccination program this month, aimed at improving...
Hubei Province Proposes National TCM Patent Medicine Procurement Alliance
The Healthcare Security Administration of Hubei Province has proposed the establishment of a national traditional...
NMPA Issues Guidelines on Medical Device Grading Administration
The National Medical Products Administration (NMPA) has released a set of Guiding Opinions on “Medical...
Frontier Biotech’s FB2001 Inhalant Accepted for NMPA Review
China-based Frontier Biotechnologies Inc. (SHA: 688221) announced that a registrational clinical filing for its FB2001...
Biden’s Executive Order Boosts US Bio-Economy, Targets China’s Biotech Rise
US President Joe Biden signed an executive order on Monday, outlining steps to bolster the...
Jiangsu Healthcare to Cover All Psychological Treatments Under BMI
The Jiangsu Provincial Healthcare Security Administration is reportedly considering adding all psychological diagnosis and treatment...
National High-Value Medical Consumables VBP Round Targets Orthopedic Spine Products
The national high-value medical consumables joint procurement office released a set of guiding opinions on...
MofCOM’s 2021 Pharma Distribution Report Shows Market Recovery
The Ministry of Commerce (MofCOM) released its annual statistical review of the pharma distribution industry...
NHSA Issues Notice on Special Treatment of Oral Implant Medical Service Charges
The National Healthcare Security Administration (NHSA) has released a Notice on “Carrying out Special Treatment...
NHSA Reveals Drugs Passing Initial Review for NRDL Inclusion
The National Healthcare Security Administration (NHSA) released a notification listing the drugs that have passed...
SAMR Issues New Rules for Online Drug Sales in China
China’s State Administration for Market Regulation (SAMR) has released the “Measures for the Supervision and...
NMPA Designates Shijiazhuang Airport as Drug Import Port for Narcotics, Psychotropics
China’s National Medical Products Administration (NMPA) has designated Shijiazhuang Airport in Hebei Province as an...
CDE Releases 62nd Batch of Chemical Generic References, Updates 39 Specifications
The Center for Drug Evaluation (CDE) has released the 62nd batch of chemical generic reference...